GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slco1b2 | affects import | ISO | SLCO1B3 (Homo sapiens) | 6480464 | CTD | SLCO1B3 protein affects the import of Sulfobromophthalein | PMID:16046661 | Slco1b2 | increases import | ISO | SLCO1B3 (Homo sapiens) | 6480464 | CTD | SLCO1B3 protein results in increased import of Sulfobromophthalein | PMID:22394605 | Slco1b2 | increases response to substance | ISO | SLCO1B3 (Homo sapiens) | 6480464 | CTD | SLCO1B3 protein results in increased susceptibility to Sulfobromophthalein | PMID:20171238 | Slco1b2 | increases uptake | ISO | SLCO1B3 (Homo sapiens) | 6480464 | CTD | SLCO1B3 protein results in increased uptake of Sulfobromophthalein | PMID:21430235 PMID:23121773 | Slco1b2 | multiple interactions | ISO | SLCO1B3 (Homo sapiens) | 6480464 | CTD | Apigenin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Clarithromycin inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Cyclosporine inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; glimepiride affects the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; kaempferol inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; naringenin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; naringin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; Nateglinide inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Pioglitazone affects the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Pravastatin inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Quercetin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; Rifampin inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein]; Rutin inhibits the reaction [SLCO1B3 protein results in increased import of Sulfobromophthalein]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased import of cyanoginosin LR]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased susceptibility to cyanoginosin LR]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased susceptibility to Okadaic Acid]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased uptake of (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased uptake of Atorvastatin]; Sulfobromophthalein inhibits the reaction [SLCO1B3 protein results in increased uptake of CCK protein modified form] | PMID:17369605 PMID:20171238 PMID:21430235 PMID:21661758 PMID:22394605 PMID:23121773 PMID:25106415 PMID:26134461 | |
Go Back to source page | Continue to Ontology report |